Jonas A Nelson, Stefan Dabic, Babak J Mehrara, Peter G Cordeiro, Joseph J Disa, Andrea L Pusic, Evan Matros, Joseph H Dayan, Robert J Allen, Michelle Coriddi, Thais O Polanco, Meghana G Shamsunder, Itay Wiser, Monica Morrow, Ahmet Dogan, Michele R Cavalli, Elizabeth Encarnacion, Meghan E Lee, Colleen M McCarthy
OBJECTIVE: This study sought to estimate the incidence and incidence rate of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) at a high-volume single institution, which enables vigorous long-term follow-up and implant tracking for more accurate estimates. SUMMARY BACKGROUND DATA: The reported incidence of BIA-ALCL is highly variable, ranging from 1 in 355 to 1 in 30,000 patients, demonstrating a need for more accurate estimates. METHODS: All patients who underwent implant-based breast reconstruction from 1991 to 2017 were retrospectively identified...
September 1, 2020: Annals of Surgery